Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/26/2025

Administration of Labetalol

Introduction to Labetalol Administration

  • The American Heart Association recommends that labetalol can be used to reduce blood pressure in patients with acute ischemic stroke, with an initial dose of 10-20 mg IV during 1-2 minutes, repeated once if necessary, in patients with systolic blood pressure >185 mmHg or diastolic >110 mmHg 1
  • The American Stroke Association suggests that labetalol 10-20 mg IV during 1-2 minutes can be administered when systolic blood pressure is >220 mmHg or diastolic is between 121-140 mmHg in patients with acute ischemic stroke not eligible for thrombolysis 2, 3

Contraindications and Precautions

  • Labetalol is contraindicated in patients with second or third degree AV block, reactive airway disease/asthma, or decompensated heart failure, as recommended by the American College of Cardiology 1
  • The American College of Cardiology advises that labetalol should be used with caution in patients with bradycardia 1

Dosage and Administration

  • The effective intravenous dose of labetalol usually ranges from 50 to 200 mg, and may require up to 300 mg in some patients, according to the American Heart Association 1
  • Labetalol begins to reduce blood pressure within 5-10 minutes, with maximum effects at 5-15 minutes and a duration of action of 3-6 hours, as stated by the American College of Cardiology 1

Patient Monitoring

  • Patients should be maintained in a supine position during intravenous administration, and blood pressure should be monitored during and after completing the infusion, as recommended by the American Heart Association 1
  • The American Stroke Association suggests avoiding rapid or excessive drops in systolic or diastolic blood pressure 1